On the role of calpain in regulation of HER2 and resistance to trastuzumab in breast cancer cells

被引：0
|
作者：
Kulkarni, S.
Reddy, K. B.
Esteva, F. J.
Budd, T. G.
Moore, H. C. F.
Tubbs, R. R.
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] MD Anderson Canc Ctr, Houston, TX USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S205 / S206
页数：2
相关论文
共 50 条
  • [1] Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
    Canonici, Alexandra
    Gijsen, Merel
    Mullooly, Maeve
    Bennett, Ruth
    Bouguern, Noujoude
    Pedersen, Kasper
    O'Brien, Neil A.
    Roxanis, Ioannis
    Li, Ji-Liang
    Bridge, Esther
    Finn, Richard
    Slamon, Dennis
    McGowan, Patricia
    Duffy, Michael J.
    O'Donovan, Norma
    Crown, John
    Kong, Anthony
    ONCOTARGET, 2013, 4 (10) : 1592 - 1605
  • [2] Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
    Fiszman, Gabriel L.
    Jasnis, Maria A.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2011, 2011
  • [3] Investigating the Role of HER4 in Relation to Trastuzumab Treatment and Resistance in HER2 Positive Breast Cancer
    Nafi, S. Mohd
    Kong, A.
    Gijsen, M.
    Kramer-Marek, G.
    Capala, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 126 - 126
  • [4] Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells
    Mao, Yan
    Zhang, Yuzi
    Qu, Qing
    Zhao, Meizhong
    Lou, Ying
    Liu, Junjun
    Huang, Ou
    Chen, Xiaosong
    Wu, Jiayi
    Shen, Kunwei
    MOLECULAR BIOSYSTEMS, 2015, 11 (04) : 1029 - 1040
  • [5] LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells
    Ding, Keshuo
    Wu, Zhengsheng
    Li, Xiaocan
    Sheng, Youjing
    Wang, Xiaonan
    Tan, Sheng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (04): : 594 - 609
  • [6] TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
    Diaz-Rodriguez, Elena
    Perez-Pena, Javier
    Rios-Luci, Carla
    Arribas, Joaquin
    Ocana, Alberto
    Pandiella, Atanasio
    CANCER LETTERS, 2019, 453 : 34 - 44
  • [7] TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
    Diaz-Rodriguez, E.
    Perez-Pena, J.
    Rios-Luci, C.
    Arribas, J.
    Ocana, A.
    Pandiella, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E11 - E11
  • [8] A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
    Menyhart, Otilia
    Santarpia, Libero
    Gyorffy, Balazs
    CURRENT CANCER DRUG TARGETS, 2015, 15 (08) : 665 - 683
  • [9] The role of adam10 in trastuzumab resistance of her2 positive breast cancer cell lines
    Feldinger, Katharina
    Gijsen, Merel
    Kong, Anthony
    CANCER RESEARCH, 2011, 71
  • [10] The Role of FGFR4 with Trastuzumab Resistance in HER2/neu-Amplified Breast Cancer
    Komforti, Miglena
    Karabakhtsian, Rouzan G.
    Albanese, Joseph
    Lo, Yungtai
    Hazan, Rachel
    LABORATORY INVESTIGATION, 2019, 99
12345